Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
Thomas R. Pieber, Marisse Asong, Gabriele Fluhr, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3716-3723
Open Access | Times Cited: 18

Showing 18 citing articles:

Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 729-738
Open Access | Times Cited: 10
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
Ulrike Hövelmann, Susanne Engberg, Tim Heise, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1941-1949
Open Access | Times Cited: 7
Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3810-3820
Open Access | Times Cited: 7
Insulin Icodec: First Approval
Hannah A. Blair
BioDrugs (2024) Vol. 38, Iss. 5, pp. 717-724
Closed Access | Times Cited: 4
Once-Weekly Insulins
J. Hans DeVries, Tim Heise
Diabetes Technology & Therapeutics (2025)
Closed Access
Pharmacokinetic properties of once‐weekly insulin icodec in Chinese individuals with type 2 diabetes
Yijun Li, Ariel Fu, Shan Jiang, et al.
Journal of Diabetes Investigation (2025)
Open Access
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
Chengyong Tang, Rui Su, Lei Wan, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus
David Q. Pham, John Andraos, Joelle Ayoub
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access
Pharmacokinetic Properties of Once‐Weekly Insulin Icodec in Children and Adolescents With Type 2 Diabetes
Michelle Van Name, Björg Ásbjörnsdóttir, Marília Brito Gomes, et al.
Pediatric Diabetes (2025) Vol. 2025, Iss. 1
Open Access
Single‐Administration Self‐Boosting Microneedle Patch for the Treatment of Obesity
Parbeen Singh, Tra Vinikoor, Nidhi Sharma, et al.
Advanced Therapeutics (2024)
Closed Access | Times Cited: 3
How Structural Modifications of Insulin Icodec Contributes to Its Prolonged Duration of Action: A Structural and Biophysical Perspective
Wei Li
(2023)
Open Access | Times Cited: 8
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications
Ylenia Ingrasciotta, Giacomo Vitturi, Gianluca Trifirò
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2113-2113
Open Access | Times Cited: 1
Insulin icodec: A novel once‐weekly treatment for diabetes
Hannah Schaffner, Jordyn Wiener, Amanda DeLuca, et al.
Diabetic Medicine (2024) Vol. 41, Iss. 10
Closed Access | Times Cited: 1
Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
Nan Dai, Xiaorong Su, Yong Wang
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes
Ildiko Lingvay, Björg Ásbjörnsdóttir, Niels Rode Kristensen, et al.
Endocrine Practice (2024)
Open Access | Times Cited: 1
Advances in insulin: a review of icodec as a novel once-weekly treatment for type 2 diabetes
Javier Morales, Aaron King, Sean M. Oser, et al.
Postgraduate Medicine (2024)
Open Access
Evaluating semaglutide + LAI-287 (IcoSema) for the treatment of diabetes mellitus type II
Maka Siamashvili, Stephen N. Davis
Expert Opinion on Pharmacotherapy (2024), pp. 1-7
Closed Access
Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes
Takashi Eto, Miwa Haranaka, Niels Rode Kristensen, et al.
Journal of Diabetes Investigation (2024)
Open Access
Page 1

Scroll to top